How do SSRIs work to treat depression?

SSRIs, or Selective Serotonin Reuptake Inhibitors, work by preventing the reuptake of serotonin from the synapse, thereby increasing its efficacy and availability to neurons. They don't increase the total amount of serotonin but make existing serotonin more effective.

What is the link between stress, cortisol, and depression?

Chronic stress leads to increased cortisol release. An abnormal cortisol pattern, like a 9 PM peak, is linked to depression. High cortisol can also disrupt the functioning of norepinephrine, dopamine, and serotonin systems.

Can exercise help with depression?

Yes, regular exercise is a protective behavior against depression and can help relieve symptoms. It increases norepinephrine, and if enjoyed, dopamine and serotonin. Exercise also positively impacts the tryptophan-to-serotonin pathway by reducing inflammation.

Are there any supplements that can help with depression?

EPAs from omega-3 fatty acids, taken at 1000-2000mg daily, can help lower inflammation and may reduce the required dose of SSRIs. Creatine supplementation has also shown promise in augmenting SSRI response, particularly in women.

What are some novel treatments for depression like ketamine and psilocybin?

Ketamine can help by creating a dissociative state, providing distance from grief and promoting neural plasticity. Psilocybin, a psychedelic, has shown robust results in clinical trials, significantly improving mood by rewiring neural circuits and alleviating depressive narratives.

Can the ketogenic diet help with depression that doesn't respond to traditional antidepressants?

For individuals with treatment-resistant depression, the ketogenic diet may offer benefits. By increasing ketone metabolism, it can modulate GABA, helping to rebalance the GABA-glutamate system, which is crucial for neuroplasticity and mood regulation.

Understanding & Conquering Depression | Huberman Lab Essentials

Q: How does inflammation contribute to depression?

Excessive inflammation, driven by cytokines, can disrupt brain function and inhibit the synthesis or release of key neurotransmitters like serotonin, dopamine, and norepinephrine. This can divert tryptophan into neurotoxic pathways, exacerbating depressive symptoms.

Andrew Huberman

Science & Technology3 min read36 min video

Jul 3, 2025|277,848 views|7,576|491

andrew huberman huberman lab podcast huberman podcast dr. andrew huberman neuroscience huberman lab andrew huberman podcast the huberman lab podcast science podcast

Save to Pod

Key Moments

TL;DR

Huberman Lab discusses depression's biology, symptoms (anhedonia, vegetative), and science-based treatments like SSRIs, ketamine, and psychedelics.

Key Insights

Major depression impacts 5% of the population and is a leading cause of disability.

Symptoms include anhedonia (lack of pleasure), grief, guilt, disrupted sleep, and vegetative symptoms.

Neurotransmitters like norepinephrine, dopamine, and serotonin play key roles in mood regulation.

Hormonal imbalances (thyroid, cortisol) and chronic stress significantly contribute to depression.

Emerging treatments like ketamine and psilocybin show promise in rewiring neural circuits and alleviating depressive symptoms.

Lifestyle interventions such as cold exposure, exercise, and EPA supplementation can positively influence mood by affecting neurochemistry and inflammation.

THE SCOPE AND SYMPTOMS OF MAJOR DEPRESSION

Major depression affects approximately 5% of the population, making it a significant cause of disability. Key symptoms extend beyond sadness to include anhedonia, a profound lack of pleasure, often described as feeling 'flat.' This condition can also manifest as delusional thinking, particularly 'anti-self-confabulation,' where individuals create narratives that inaccurately portray themselves as sicker or less functional than they are. Furthermore, 'vegetative symptoms' like persistent exhaustion and disrupted sleep patterns, such as early morning waking, are common physiological indicators.

NEUROTRANSMITTERS AND THEIR ROLE IN MOOD

Decades of research have identified critical neurotransmitter systems involved in depression. Early antidepressants, like TCAs and MAOIs, primarily targeted norepinephrine, influencing alertness and energy levels. Later, the dopamine system, crucial for pleasure and motivation, was implicated, explaining anhedonia. Selective serotonin reuptuptake inhibitors (SSRIs) emerged, focusing on increasing serotonin availability in the synapse, which is thought to regulate grief and guilt. While these systems are interconnected, imbalances in norepinephrine, dopamine, and serotonin contribute to distinct depressive symptoms.

HORMONAL INFLUENCES AND THE IMPACT OF STRESS

Hormonal factors play a significant role in the development and persistence of depression. Low thyroid hormone levels can lead to reduced energy and brain metabolism, sometimes necessitating thyroid medication for relief. Postpartum depression and mood disturbances related to menstrual cycles and menopause highlight the direct impact of hormonal shifts. Chronic stress is strongly correlated with increased cortisol levels, which can disrupt the functioning of key neurotransmitters and elevate the risk of experiencing multiple depressive episodes, underscoring the importance of stress management.

GENETIC PREDISPOSITION AND ENVIRONMENTAL TRIGGERS

While not solely genetic, there is a clear inherited predisposition to major depression. Studies on identical twins show a 50% concordance rate, indicating that genetics play a substantial role, though other factors are clearly involved. This genetic vulnerability means that individuals with a family history of depression may be more susceptible. Stress is identified as a primary trigger that can activate this predisposition, turning a genetic likelihood into an actual depressive episode. Therefore, understanding and mitigating stress is a crucial preventative measure.

INFLAMMATION AS A CONTRIBUTOR TO DEPRESSION

Emerging evidence strongly links chronic inflammation to many forms of major depression. Inflammatory cytokines, such as IL-6 and TNF-alpha, can disrupt the synthesis and release of key neurotransmitters like serotonin, dopamine, and norepinephrine. This occurs partly by diverting tryptophan, a precursor for serotonin, down a neurotoxic pathway. Reducing inflammation through interventions like increasing EPA (eicosapentaenoic acid) intake from omega-3 fatty acids or regular exercise can help protect these crucial neurotransmitter pathways and potentially improve mood, even reducing the required dosage of certain antidepressants.

NOVEL THERAPIES AND LIFESTYLE INTERVENTIONS

Beyond traditional antidepressants, innovative treatments are showing significant promise. Ketamine can induce dissociative states, offering distance from overwhelming grief and facilitating neural plasticity. Psychedelic compounds like psilocybin, particularly when used in assisted therapy, have demonstrated substantial improvement in mood by potentially rewiring neural circuits and altering emotional associations. Lifestyle interventions, including deliberate cold exposure to boost norepinephrine, regular exercise benefiting multiple neurotransmitter systems, and EPA supplementation to combat inflammation, are also powerful tools for managing and preventing depressive symptoms.

DIETARY APPROACHES AND SUPPLEMENTATION

Nutritional strategies can also play a role in managing depression. While some diets lack robust data, the ketogenic diet shows promise, particularly for individuals with treatment-resistant depression. By shifting the brain's metabolism to ketones, this diet can modulate the GABA-glutamate balance, which is vital for brain activity and neuroplasticity. Supplementation with creatine has also been found to augment the effectiveness of SSRIs, especially in women with major depressive disorder, by supporting the brain's phosphocreatine system, which is involved in mood regulation.

Mentioned in This Episode

●Supplements

●Tools

●Books

●Concepts

●People Referenced

Neurochemical Systems and Depression Symptoms

Data extracted from this episode

Neurotransmitter/System	Associated Symptoms in Depression	Function
Norepinephrine	Psychomotor defects, lethargy, exhaustion, inability to get out of bed	Activity and alertness
Dopamine	Anhedonia (lack of pleasure)	Motivation, pleasure, ability to seek and experience pleasure
Serotonin	Grief, guilt, emotional aspects	Mood regulation, emotional processing

Common Questions

Key symptoms include persistent grief and sadness, anhedonia (lack of pleasure), negative delusional thinking (anti-self confabulation), and vegetative symptoms like constant exhaustion and disrupted sleep patterns, such as early waking.

Topics

Major Depression

Mentioned in this video

bookThe American Journal of Psychiatry

Published a 2012 study on creatine monohydrate's effect on major depressive disorder.

conceptanhedonia

A general lack of ability to enjoy things or experience pleasure, observed as a flat affect in depression.

drugfluoxetine

The generic name for Prozac, a selective serotonin reuptake inhibitor (SSRI).

conceptinflammation

Excessive and chronic inflammation in the brain and body is increasingly linked to the development and exacerbation of depression.

conceptanti-self confabulation

Delusional thinking where confabulations are self-deprecating and not linked to reality, making the person seem sicker.

conceptvegetative symptoms

Physiological symptoms of depression that occur without conscious thought, such as constant exhaustion and disrupted sleep patterns.

conceptserotonin pathway

The biochemical pathway responsible for converting tryptophan into serotonin, which can be compromised by inflammation.

conceptmajor depression

Distinguished from bipolar depression, impacting 5% of the population and is the number four cause of disability.

conceptpostpartum depression

Depression experienced by women after childbirth, often thought to be hormonally related.

drugtricyclic antidepressants

One of the earliest categories of antidepressants discovered, working by increasing norepinephrine levels, but with significant side effects.

toolcold showers

A behavioral tool that can increase norepinephrine and epinephrine levels, potentially helping with aspects of depression.

supplementEPAs

Essential fatty acids, particularly the EPA variety of omega-3s, recommended at 1000-2000mg daily to lower inflammation and potentially reduce SSRI dosage.

toolZoloft

organizationJAMA Psychiatry